000 01190 a2200337 4500
005 20250513221514.0
264 0 _c20001004
008 200010s 0 0 eng d
022 _a0954-6111
024 7 _a10.1016/s0954-6111(00)90123-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTashkin, D P
245 0 0 _aHFA-BDP and its implications for the quiet zone.
_h[electronic resource]
260 _bRespiratory medicine
_cSep 2000
300 _aS37-9 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdministration, Topical
650 0 4 _aAerosol Propellants
650 0 4 _aAnti-Asthmatic Agents
_xpharmacology
650 0 4 _aAnti-Inflammatory Agents
_xpharmacology
650 0 4 _aAsthma
_xdiagnostic imaging
650 0 4 _aBeclomethasone
_xpharmacology
650 0 4 _aBronchi
_xdrug effects
650 0 4 _aBronchography
_xmethods
650 0 4 _aGlucocorticoids
650 0 4 _aHumans
650 0 4 _aHydrocarbons, Fluorinated
650 0 4 _aTomography, X-Ray Computed
_xmethods
773 0 _tRespiratory medicine
_gvol. 94 Suppl D
_gp. S37-9
856 4 0 _uhttps://doi.org/10.1016/s0954-6111(00)90123-9
_zAvailable from publisher's website
999 _c10949130
_d10949130